Browsing Tag: Phase 3 Trial

Key Highlights:  Implications:  Wockhardt’s SEC nod for Zaynich marks a major step toward India’s first home-grown, dual‑mechanism anti‑Gram‑negative launched in the carbapenem‑resistan...